| Low molecular weight heparin for acute ischemic heart disease. | |
| | |
MedLine Citation:
|
PMID: 9134269 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
LMWH seems to me to be an attractive antithrombotic therapy that can be used in combination with antiplatelet treatment in patients with acute coronary syndromes. One of the advantages of LMWH is that home treatment becomes a possibility since the agent can be administered as subcutaneous injection without monitoring coagulation times. Therefore, in some patients, once they are stabilized and past the acute event, outpatient subcutaneous treatment with LMWH could be an attractive alternative to impatient treatment with intravenous heparin. |
| | |
Authors:
|
C R Conti |
Related Documents
:
|
22674649 - Treatment of burn scars with the 1,550 nm nonablative fractional erbium laser. 20434759 - Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee... 1588809 - Comparison of the influence of intralumenal irrigation solutions on free flap survival. 17689769 - Thromboembolism in patients undergoing total knee arthroplasty with epidural analgesia. 1527149 - Management of thrombophlebitis in the prepartum period. a case report. 19710609 - Animal model and clinical evidence indicating low thrombogenic potential of fibrinogen ... 22066099 - Hybrid surgery versus percutaneous mechanical thrombectomy for the thrombosed hemodialy... 12605519 - Influence of lip repair on craniofacial morphology of patients with complete bilateral ... 3606849 - Malignant external otitis. comparison of monotherapy vs combination therapy. |
Publication Detail:
|
Type: Editorial |
Journal Detail:
|
Title: Clinical cardiology Volume: 20 ISSN: 0160-9289 ISO Abbreviation: Clin Cardiol Publication Date: 1997 May |
Date Detail:
|
Created Date: 1997-07-17 Completed Date: 1997-07-17 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7903272 Medline TA: Clin Cardiol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 415-6 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Anticoagulants / administration & dosage, therapeutic use* Clinical Trials as Topic Dalteparin / administration & dosage, therapeutic use Drug Administration Routes Electrocardiography Heparin, Low-Molecular-Weight / administration & dosage, therapeutic use* Humans Myocardial Ischemia / drug therapy*, physiopathology Nadroparin / administration & dosage, therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Dalteparin; 0/Heparin, Low-Molecular-Weight; 0/Nadroparin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Positive and negative effects of a child sexual abuse prevention program.
Next Document: Alcohol, ischemic heart disease, and the French paradox.